Cencora (COR) Income from Non-Controlling Interests (2018 - 2026)
Cencora (COR) reported Income from Non-Controlling Interests of -$11.8 million for Q1 2026, down 2500.0% on a YoY basis from $491833.3 in Q1 2025, and down 282.19% quarter-over-quarter from $6.5 million in Q4 2025.
Cencora (COR) Income from Non-Controlling Interests (2018 - 2026) Analysis & Trends
Cencora has reported Income from Non-Controlling Interests for 9 years, with the latest figure at -$11.8 million in Q1 2026.
- For the quarter ending Q1 2026, Income from Non-Controlling Interests fell 2500.0% year-over-year to -$11.8 million; the trailing twelve-month figure through Mar 2026 stood at $3.7 million (down 71.62% YoY), and the FY2025 full-year result was $13.6 million, up 34.39% from the prior year.
- Income from Non-Controlling Interests for Q1 2026 stood at -$11.8 million, down from $6.5 million in the prior quarter.
- The five-year high for Income from Non-Controlling Interests was $7.2 million in Q1 2022, with the low at -$43.8 million in Q2 2022.
- Historically, Income from Non-Controlling Interests has averaged -$1.6 million across 5 years, with a median of $1.5 million in 2023.
- Annual changes were most pronounced in 2024 — Income from Non-Controlling Interests jumped 1222.55% — and 2026, when it plunged 2500.0%.
- Cencora's Income from Non-Controlling Interests stood at -$3.6 million in 2022, then soared by 142.18% to $1.5 million in 2023, then soared by 239.46% to $5.1 million in 2024, then climbed by 26.57% to $6.5 million in 2025, then tumbled by 282.19% to -$11.8 million in 2026.
- The last three Income from Non-Controlling Interests figures came in at -$11.8 million (Q1 2026), $6.5 million (Q4 2025), and $6.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Akso Health | 2,315,158.81 Bn | 2,315,158.63 Bn | - | - |
| 2 | Mckesson | 92.76 Bn | 89.18 Bn | 4.04 Bn | 173.00 Mn |
| 3 | Cencora | 52.82 Bn | 50.83 Bn | 3.59 Bn | -11.80 Mn |
| 4 | Cardinal Health | 52.17 Bn | 48.39 Bn | 2.50 Bn | -19.00 Mn |
| 5 | Henry Schein | 9.19 Bn | 9.71 Bn | 1.07 Bn | 5.00 Mn |
| 6 | Accendra Health | 246.88 Mn | -90.00 Mn | 312.39 Mn | - |
| 7 | Edap Tms | 161.92 Mn | 146.92 Mn | 8.15 Mn | - |
| 8 | 111 | 107.47 Mn | 25.61 Mn | 23.58 Mn | 30,000.00 |
| 9 | Cosmos Health | 9.42 Mn | 7.26 Mn | 1.38 Mn | - |
| 10 | Cellyan Biotechnology | 5.69 | -2.48 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -11.80 Mn |
| Dec 31, 2025 | 6.48 Mn |
| Sep 30, 2025 | 6.63 Mn |
| Jun 30, 2025 | 2.35 Mn |
| Mar 31, 2025 | -454,000.00 |
| Dec 31, 2024 | 5.12 Mn |
| Sep 30, 2024 | 4.08 Mn |
| Jun 30, 2024 | 4.13 Mn |
| Mar 31, 2024 | 430,000.00 |
| Dec 31, 2023 | 1.51 Mn |
| Sep 30, 2023 | -1.59 Mn |
| Jun 30, 2023 | -368,000.00 |
| Mar 31, 2023 | -7.19 Mn |
| Dec 31, 2022 | -3.58 Mn |
| Sep 30, 2022 | 3.94 Mn |
| Jun 30, 2022 | -43.76 Mn |
| Mar 31, 2022 | 7.23 Mn |
| Dec 31, 2021 | 311,000.00 |
| Sep 30, 2021 | -1.25 Mn |
| Jun 30, 2021 | 3.33 Mn |